Similar articles

• Live donor liver transplantation for primary sclerosing cholangitis: is disease recurrence increased?

  Graziadei IW. Graziadei IW. Curr Opin Gastroenterol. 2011 May;27(3):301-5. doi: 10.1097/MOG.0b013e3283437a8c. Curr Opin Gastroenterol. 2011. PMID: 21248637 Review.
• Liver transplantation for cholestatic liver disease: screening and assessment of risk factors.

  Crippin JS. Crippin JS. Liver Transpl Surg. 1998 Sep;4(5 Suppl 1):S2-8. Liver Transpl Surg. 1998. PMID: 9742488 Review.
• Frequent overlap of active hepatitis in recurrent primary sclerosing cholangitis after living-donor liver transplantation relates to its rapidly progressive course.

  Miyagawa-Hayashino A, Egawa H, Yoshizawa A, Ueda Y, Ichida T, Ueno Y, Uemoto S, Harada K, Nakanuma Y. Miyagawa-Hayashino A, et al. Hum Pathol. 2011 Sep;42(9):1329-36. doi: 10.1016/j.humpath.2010.01.029. Epub 2011 Feb 21. Hum Pathol. 2011. PMID: 21334714
• A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts.

  Alabraba E, Nightingale P, Gunson B, Hubscher S, Olliff S, Mirza D, Neuberger J. Alabraba E, et al. Liver Transpl. 2009 Mar;15(3):330-40. doi: 10.1002/lt.21679. Liver Transpl. 2009. PMID: 19243003
• Recurrence of primary sclerosing cholangitis after living donor liver transplantation.

  Tamura S, Sugawara Y, Kaneko J, Matsui Y, Togashi J, Makuuchi M. Tamura S, et al. Liver Int. 2007 Feb;27(1):86-94. doi: 10.1111/j.1478-3231.2006.01395.x. Liver Int. 2007. PMID: 17241386